RushallB.JonesM., The Anti-Drugs-in-Sport Movement: Causes for Concern, International Journal of Sports Science and Coaching, 2006, 1(1), 1–18.
2.
CalfeeR.FadaleP., Popular Ergogenic Drugs and Supplements in Young Athletes, Pediatrics, 2006, 117(3), e577–89.
3.
DharR.StoutC.W.LinkM.S.HomoudM.K.WeinstockJ., Estes N.A. 3rd., Cardiovascular Toxicities of Performance-Enhancing Substances in Sports, Mayo Clinic Proceedings, 2005, 80(10), 1307–15.
4.
DiLuigi L.RomanelliF.LenziA., Androgenic-anabolic steroids abuse in male. Journal of Endocrinology Investigations, 2005, 28(3) Suppl, 81–4.
5.
MaraveliasC.DonaA. Stefanidou M.SpiliopoulouC., Adverse Effects of Anabolic Steroids in Athletes, A Constant Threat, Toxicology Letters, 2005, 158(3), 167–75.
ClarkB.M.SchofieldR.S., Dilated Cardiomyopathy and Acute Liver Injury Associated with Combined Use of Ephedra, Gamma-Hydroxybutyrate, and Anabolic Steroids, Pharmacotherapy, 2005, 25(5), 756–61.
8.
SocasL.ZumbadoM. Perez-Luzardo O.RamosA.PerezC.HernandezJ.R.BoadaL.D., Hepatocellular Adenomas Associated with Anabolic Androgenic Steroid Abuse in Bodybuilders: A Report of Two Cases and a Review of the Literature, British Journal of Sports Medicine, 2005, 39(5), e27.
9.
du ToitE.F.RossouwE.Van RooyenJ.LochnerA., Proposed Mechanisms for the Anabolic Steroid-Induced Increase in Myocardial Susceptibility to Ischaemia/Reperfusion Injury, Cardiovascular Journal of South Africa, 2005, 16(1), 21–2.
10.
BahrkeM.S.YesalisC.E., Abuse of Anabolic Androgenic Steroids and Related Substances in Sport and Exercise, Current Opinions in Pharmacology, 2004, 4(6), 614–20.
11.
HartgensF.KuipersH., Effects of Androgenic-Anabolic Steroids in Athletes, Sports Medicine, 2004, 34(8), 513–54.
12.
UrhausenA.AlbersT.KindermannW., Are the Cardiac Effects of Anabolic Steroid Abuse in Strength Athletes Reversible?, Heart, 2004, 90(5), 496–501.
13.
AyotteC.LevesqueJ.F.ClerouxM.LajeunesseA.GoudreaultD.FakirianA., Sport Nutritional Supplements: Quality and Doping Controls, Canadian Journal of Applied Physiology, 2001, 26, S120–129.
14.
LabrieF.Luu-TheV.CalvoE.MartelC.CloutierJ. Gauthier S.BelleauP.MorissetteJ.LévesqueM. H.LabrieC., Tetrahydrogestrinone Induces a Genomic Signature Typical of a Potent Anabolic Steroid, Journal of Endocrinology, 2005, 184(2), 427–33.
